2 completed, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow GEN-003: new trials by email Literature Review of GEN-003 trials Research Report on GEN-003
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection GEN-003, Matrix-M2, 0.9% normal saline - Genital Herpes, HSV-2 Infection | Phase 2 | Terminated | Genocea Biosciences, Inc. | 33 | 2017-05-24 | 2019-02-19 |
| Evaluating New Formulation of Therapeutic HSV-2 Vaccine Matrix-M2, GEN-003, Placebo - Genital Herpes Simplex Type 2 | Phase 2 | Completed | Genocea Biosciences, Inc. | 131 | 2015-11-01 | 2018-05-22 |
| Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine GEN-003 with Matrix M-2, GEN-003, Placebo - Genital Herpes Simplex Type 2 | Phase 1 / Phase 2 | Completed | Genocea Biosciences, Inc. | 143 | 2012-07-01 | 2018-06-01 |
Herpes Simplex (3) · Herpes Genitalis (2)
United States (3)